MedBlog

David Fudman, M.D.

New IBD therapies take the ‘if factor’ out of Crohn’s, ulcerative colitis

Three new types of IBD medication – IL-23 selective inhibitors, S1P modulators, and JAKi agents – offer patients a chance at freedom from the disruptive symptoms of Crohn's disease and ulcerative colitis.

David Fudman, M.D.

August 19, 2025